FPF
NTLA icon

First Pacific Financial’s Intellia Therapeutics NTLA Stock Holding History

First Pacific Financial’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2
Closed -$15 – 565
2025
Q1 		$15 Sell
2
-416
-100% -$4.2K ﹤0.01% 526
2024
Q4 		$4.87K Hold
418
– – ﹤0.01% 321
2024
Q3 		$8.59K Hold
418
– – ﹤0.01% 271
2024
Q2 		$9.36K Hold
418
– – ﹤0.01% 259
2024
Q1 		$11.5K Hold
418
– – ﹤0.01% 255
2023
Q4 		$12.7K Hold
418
– – ﹤0.01% 241
2023
Q3 		$13.2K Buy
+418
New +$16.2K 0.01% 209

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $47.9M AUM 29.29% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Pacific Financial's NTLA Position: Q2 2025 in Review

First Pacific Financial sold out of Intellia Therapeutics (NTLA) in Q2 2025, closing a stake of 2 shares — an estimated $15 sold.

First Pacific Financial first reported a position in NTLA in Q3 2023 and held it in 7 quarters. The position peaked at $13.2K in Q3 2023. 280 funds tracked by Wall St. Rank hold NTLA as of Q2 2025.

  • First Pacific Financial reported no remaining Intellia Therapeutics position as of Q2 2025 after selling out during the quarter.
  • First Pacific Financial sold 2 Intellia Therapeutics shares in Q2 2025, an estimated $15.
  • First Pacific Financial first reported a position in Intellia Therapeutics in Q3 2023 and held it in 7 quarters.
  • First Pacific Financial's Intellia Therapeutics position peaked at $13.2K in Q3 2023.
  • 280 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q2 2025.

Based on First Pacific Financial's 13F filing for Q2 2025, filed 18 Jul 2025.